| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.97▼ | 9.98▼ | 9.97▼ | 9.97▼ | 9.90▲ |
| MA10 | 9.96▼ | 9.95▲ | 9.96▼ | 9.93▲ | 9.85▲ |
| MA20 | 9.96▼ | 9.97▼ | 9.95▲ | 9.89▲ | 9.79▲ |
| MA50 | 9.90▲ | 9.88▲ | 9.87▲ | 9.82▲ | 9.79▲ |
| MA100 | 9.85▲ | 9.84▲ | 9.84▲ | 9.78▲ | 9.50▲ |
| MA200 | 9.82▲ | 9.78▲ | 9.75▲ | 9.83▲ | 9.08▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.004▼ | -0.003▼ | 0.006▲ | 0.022▲ |
| RSI | 52.208▲ | 52.266▲ | 53.092▲ | 57.950▲ | 57.447▲ |
| STOCH | 78.583 | 72.914 | 63.893 | 81.313▲ | 83.508▲ |
| WILL %R | -30.435 | -44.828 | -44.828 | -22.727▲ | -8.197▲ |
| CCI | 14.789 | -15.405 | -29.281 | 67.743 | 135.055▲ |
|
Saturday, November 08, 2025 01:13 AM
(RTTNews) - Takeda Pharmaceutical Company Limited (TAK) announced new interim findings from its Phase 1b open-label proof-of-concept trial evaluating subcutaneous mezagitamab (TAK-079), an anti-CD38 ...
|
|
Monday, May 05, 2025 03:27 PM
We have seen 19 institutional investors add shares of $IGA stock to their portfolio, and 20 decrease their positions in their most recent quarter.
|
|
Saturday, October 26, 2024 07:45 AM
(RTTNews) - Travere Therapeutics Inc. (TVTX) announced that new data further demonstrates the clinical benefit of FILSPARI (sparsentan) in IgA nephropathy (IgAN) and reinforces its potential in focal ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/02/26 | 9.95 | 10.00 | 9.88 | 9.97 | 54,100 |
| 12/02/26 | 9.98 | 9.99 | 9.88 | 9.94 | 33,000 |
| 11/02/26 | 10.02 | 10.02 | 9.91 | 9.98 | 73,600 |
| 10/02/26 | 10.00 | 10.02 | 9.97 | 9.98 | 61,100 |
| 09/02/26 | 9.94 | 10.00 | 9.91 | 10.00 | 55,300 |
| 06/02/26 | 9.85 | 9.98 | 9.83 | 9.95 | 92,800 |
| 05/02/26 | 9.80 | 9.89 | 9.80 | 9.83 | 69,000 |
| 04/02/26 | 9.89 | 9.92 | 9.86 | 9.91 | 49,200 |
| 03/02/26 | 9.90 | 9.91 | 9.84 | 9.86 | 47,700 |
| 02/02/26 | 9.89 | 9.9089 | 9.86 | 9.90 | 56,975 |
|
|
||||
|
|
||||
|
|